WO 2017/187426 Al 02 November 2017 (02.11.2017) W !P O PCT
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/187426 Al 02 November 2017 (02.11.2017) W !P O PCT (51) International Patent Classification: SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, TR, C12N 15/113 (2010.01) TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (21) International Application Number: (84) Designated States (unless otherwise indicated, for every PCT/IB20 17/052505 kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (22) International Filing Date: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 28 April 2017 (28.04.2017) TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (25) Filing Language: English EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (26) Publication Langi English TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (30) Priority Data: KM, ML, MR, NE, SN, TD, TG). 62/329,537 29 April 2016 (29.04.2016) US Declarations under Rule 4.17: (71) Applicant: APTAMIR THERAPEUTICS, INC. — as to applicant's entitlement to apply for and be granted a [US/US]; 3925 W. Braker Lane, Austin, Texas 78759 (US). patent (Rule 4.1 7(H)) (72) Inventor: THIBONNIER, Marc; AptamiR Therapeutics, Published: Inc., 484 Terracina Way, Naples, Florida 341 19 (US).
[Show full text]